AU:LTP Stock Latest News
Company AnnouncementsLTR Pharma Secures Indian Patent for SPONTAN and ROXUS Technology4d agoLTP
Company AnnouncementsLTR Pharma Applies to Quote 198,595 Ordinary Shares1w agoLTP
Company AnnouncementsLTR Pharma Director Receives Two Million Incentive Options1w agoLTP
Company AnnouncementsLTR Pharma Grants Director One Million Incentive Options1w agoLTP
Company AnnouncementsLTR Pharma Director Receives One Million Incentive Options1w agoLTP
Company AnnouncementsLTR Pharma advances U.S. ROXUS launch and FDA pathway for SPONTAN2w agoLTPCompany AnnouncementsLTR Pharma to Test Intranasal SPONTAN in Pulmonary Arterial Hypertension Trial3w agoLTP
Company AnnouncementsLTR Pharma marks 2,000 SPONTAN units as intranasal ED spray gains traction3w agoLTP- Company AnnouncementsLTR Pharma to Present Phase II Data and U.S. ROXUS Update in Investor Webinar1M agoLTP
Company AnnouncementsLTR Pharma Fulfils First U.S. ROXUS Prescriptions via Telehealth Channel1M agoLTP- Company AnnouncementsLTR Pharma to Showcase Clinical Data and Commercial Momentum in Upcoming Investor Webinar1M agoLTP
Company AnnouncementsLTR Pharma completes FDA pharmacokinetic dataset as SPONTAN shows rapid absorption and strong safety1M agoLTPCompany AnnouncementsLTR Pharma Sets October AGM as It Expands Intranasal Therapeutics Portfolio1M agoLTP
- Company AnnouncementsLTR Pharma Seeks ASX Quotation for Additional Ordinary Shares2M agoLTP
Company AnnouncementsLTR Pharma outlines specialty therapy focus and restricts investor presentation use2M agoLTP- Company AnnouncementsLTR Pharma moves into oral testosterone with KYZATREX pilot deal2M agoLTP
- Company AnnouncementsLTR Pharma Issues Unquoted Performance Rights Under Employee Incentive Scheme4M agoLTP
Company AnnouncementsLTR Pharma Wins Ethics Nod for First GI Trial of Intranasal OROFLOW4M agoLTP
Company AnnouncementsLTR Pharma outlines limits and legal caveats in latest investor update6M agoLTP